Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
Is a
Allocation Type
Randomized
0
Participating Facility
Health Conditions in Trial
Intervention Model
Sequential Assignment
0
Intervention Name
PTX-022
0
Placebo
0
Interventional Trial Phase
Phase 3
0
Phase 2
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
August 19, 2020
0
Masked Party
Investigator
0
Participant
0
Masking Type
Double
0
Primary Completion Date
2020
0
Trial Recruitment Size
73
0
Trial Sponsor
Clinical Trial Start Date
April 1, 2019
0
Study Completion Date
2020
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Multicenter, Four-Part, Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Adults With Moderate to Severe Pachyonychia Congenita
0
Official Website
Find more entities like Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.